InvestorsHub Logo
Followers 16
Posts 395
Boards Moderated 0
Alias Born 12/05/2012

Re: blackhawks post# 63271

Thursday, 03/07/2013 3:00:04 PM

Thursday, March 07, 2013 3:00:04 PM

Post# of 130503
Today's SI report has everything to do with AMBS and Banyan's study.
http://sportsillustrated.cnn.com/more/news/20130307/new-blood-test-for-brain-damage/

You do remember that they are presenting together.... ....today......at the TBI conference, correct? .......?

Come on ...its exhausting throwing real facts, not rah-rah fluff, but real facts out with the same tired responses.

Banyan received a $26M DOD contract in 2010 to pursue TBI research....AMBS/Banyan study was part of that. Documented. Done. No mystery.

Once again for those in the cheap seats...

Documented timeline of Banyan and AMBS relationship.

Jan 2012 Amarantus is introduced to Banyan by the US Dept of Defense to pursue interests in identifying and treating brain trauma.
http://www.drugdiscoverynews.com/index.php?newsarticle=5717

June 2012 –AMBS and Banyan report that “"data give us confidence to move to the next phase of testing to further validate this approach, as well as look at innovative product development strategies to accelerate bringing a MANF-based treatment to patients for TBI."
http://content.stockpr.com/_news/amarantus/2012-06-07_Amarantus_BioSciences_and_Banyan_Biomarkers_Announ_13.pdf

Today
Banyan AND AMBS have something to talk about at TBI conference???
http://www.tbiconference.com/home/speakers

...sounds like it to me. AMBS+Banyan=blood test and treatment for TBI!!

"Amarantus BioSciences Inc. (OTCBB:AMBS), Sunnyvale, Calif. Banyan Biomarkers Inc., Alachua, Fla. Business: Neurology Amarantus partnered with Banyan to develop Amarantus' mesencephalic astrocyte-derived neurotrophic"